327
Views
23
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE Cellular and Molecular Biology

Modulatory Effects of Acetazolomide and Dexamethasone on Temozolomide Mediated Apoptosis in Human Glioblastoma T98G and U87MG Cells

, &
Pages 352-358 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Daniel Stieber, Siti A Abdul Rahim & Simone P Niclou. (2011) Novel ways to target brain tumour metabolism. Expert Opinion on Therapeutic Targets 15:10, pages 1227-1239.
Read now

Articles from other publishers (22)

Shohini Banerjee, Ian M Smith, Autumn C Hengen & Kimberly M Stroka. (2023) Methods for studying mammalian aquaporin biology. Biology Methods and Protocols 8:1.
Crossref
Kai Zhao, Agnes Schäfer, Zhuo Zhang, Katharina Elsässer, Carsten Culmsee, Li Zhong, Axel Pagenstecher, Christopher Nimsky & Jörg W. Bartsch. (2021) Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells. International Journal of Molecular Sciences 23:1, pages 157.
Crossref
Seán B. Lyne & Bakhtiar Yamini. (2021) An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma. Cancers 13:8, pages 1953.
Crossref
Przemyslaw Wielgat, Natalia Wawrusiewicz-Kurylonek, Robert Czarnomysy, Karol Rogowski, Krzysztof Bielawski & Halina Car. (2021) The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model. International Journal of Molecular Sciences 22:4, pages 1791.
Crossref
Sang Y. Lee & Gaspar J. Kitange. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 79 133 .
Kristen W. Carlson, Jack A. Tuszynski, Socrates Dokos, Nirmal Paudel, Thomas Dreeben & Ze’ev Bomzon. 2021. Brain and Human Body Modeling 2020. Brain and Human Body Modeling 2020 19 35 .
Ricarda Hannen, Martin Selmansberger, Maria Hauswald, Axel Pagenstecher, Andrea Nist, Thorsten Stiewe, Till Acker, Barbara Carl, Christopher Nimsky & Jörg Walter Bartsch. (2019) Comparative Transcriptomic Analysis of Temozolomide Resistant Primary GBM Stem-Like Cells and Recurrent GBM Identifies Up-Regulation of the Carbonic Anhydrase CA2 Gene as Resistance Factor. Cancers 11:7, pages 921.
Crossref
Ilhan Elmaci, Aysel Ozpinar, Alp Ozpinar, Jennifer L. Perez & Meric A. Altinoz. (2019) From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D + all-trans retinoic acid + Temozolomide combination in treatment of GBM. Metabolic Brain Disease 34:3, pages 687-704.
Crossref
Marta Cenciarini, Mario Valentino, Silvia Belia, Luigi Sforna, Paolo Rosa, Simona Ronchetti, Maria Cristina D’Adamo & Mauro Pessia. (2019) Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies. Frontiers in Molecular Neuroscience 12.
Crossref
Richard Kast. (2018) Paths for Improving Bevacizumab Available in 2018: The ADZT Regimen for Better Glioblastoma Treatment. Medical Sciences 6:4, pages 84.
Crossref
Longtao Wu, Giovanna M. BernalKirk E. CahillPeter PytelCarrie A. FitzpatrickHeather MashekRalph R. Weichselbaum & Bakhtiar Yamini. (2018) BCL3 expression promotes resistance to alkylating chemotherapy in gliomas . Science Translational Medicine 10:448.
Crossref
Nathaniel H. Boyd, Kiera Walker, Joshua Fried, James R. Hackney, Paul C. McDonald, Gloria A. Benavides, Raffaella Spina, Alessandra Audia, Sarah E. Scott, Catherine J. Libby, Anh Nhat Tran, Mark O. Bevensee, Corinne Griguer, Susan Nozell, G. Yancey Gillespie, Burt Nabors, Krishna P. Bhat, Eli E. Bar, Victor Darley-Usmar, Bo Xu, Emily Gordon, Sara J. Cooper, Shoukat Dedhar & Anita B. Hjelmeland. (2017) Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. JCI Insight 2:24.
Crossref
Josef Finsterer & Fulvio A. Scorza. (2017) Effects of antiepileptic drugs on mitochondrial functions, morphology, kinetics, biogenesis, and survival. Epilepsy Research 136, pages 5-11.
Crossref
Abdolali Amiri, Phuong Uyen Le, Alexandre Moquin, Gayane Machkalyan, Kevin Petrecca, John W. Gillard, Nathan Yoganathan & Dusica Maysinger. (2016) Inhibition of carbonic anhydrase IX in glioblastoma multiforme. European Journal of Pharmaceutics and Biopharmaceutics 109, pages 81-92.
Crossref
Ching-Yi Lee, Hung-Yi Lai, Angela Chiu, She-Hung Chan, Ling-Ping Hsiao & Shih-Tseng Lee. (2016) The effects of antiepileptic drugs on the growth of glioblastoma cell lines. Journal of Neuro-Oncology 127:3, pages 445-453.
Crossref
Erik R. Swenson. 2016. Hypoxia. Hypoxia 301 323 .
Ramzi M. Mohammad, Irfana Muqbil, Leroy Lowe, Clement Yedjou, Hsue-Yin Hsu, Liang-Tzung Lin, Markus David Siegelin, Carmela Fimognari, Nagi B. Kumar, Q. Ping Dou, Huanjie Yang, Abbas K. Samadi, Gian Luigi Russo, Carmela Spagnuolo, Swapan K. Ray, Mrinmay Chakrabarti, James D. Morre, Helen M. Coley, Kanya Honoki, Hiromasa Fujii, Alexandros G. Georgakilas, Amedeo Amedei, Elena Niccolai, Amr Amin, S. Salman Ashraf, William G. Helferich, Xujuan Yang, Chandra S. Boosani, Gunjan Guha, Dipita Bhakta, Maria Rosa Ciriolo, Katia Aquilano, Sophie Chen, Sulma I. Mohammed, W. Nicol Keith, Alan Bilsland, Dorota Halicka, Somaira Nowsheen & Asfar S. Azmi. (2015) Broad targeting of resistance to apoptosis in cancer. Seminars in Cancer Biology 35, pages S78-S103.
Crossref
Walter Lemmo. (2014) Potential interactions of prescription and over‐the‐counter medications having antioxidant capabilities with radiation and chemotherapy. International Journal of Cancer 137:11, pages 2525-2533.
Crossref
Patrick Roth, Caroline Happold & Michael Weller. (2015) Corticosteroid use in neuro-oncology: an update. Neuro-Oncology Practice 2:1, pages 6-12.
Crossref
Richard E. Kast, Georg Karpel-Massler & Marc-Eric Halatsch. (2014) CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget 5:18, pages 8052-8082.
Crossref
L. Emdad, Z. A. Qadeer, L. B. Bederson, H. P. Kothari, M. Uzzaman & I. M. Germano. (2011) Is there a common upstream link for autophagic and apoptotic cell death in human high-grade gliomas?. Neuro-Oncology 13:7, pages 725-735.
Crossref
Patrick Roth, Wolfgang Wick & Michael Weller. (2010) Steroids in neurooncology: actions, indications, side-effects. Current Opinion in Neurology 23:6, pages 597-602.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.